On 23rd July, I’m officially launching Sharon Shields Consulting — a specialist consultancy focused on executive research, market mapping and talent intelligence for life sciences organisations across the UK, Europe and the US. I also partner with executive search consultancies who need deep, reliable research support for complex senior mandates.

For generations, treating cancer has relied on a pretty brutal calculus: hit the body hard and hope the cancer dies first. Traditional chemotherapy is essentially a scorched-earth strategy. It works, but at a massive cost—wrecking the heart, gut, and nervous system along with the tumour. . For decades, researchers have chased a deceptively simple question: What if we could send the drug only where it’s actually needed? Antibody-drug conjugates, or ADCs, are the most promising

For decades, psychiatric drug development has operated with a deceptively simple story. Mental illness lives in the brain. Depression is a serotonin problem. Drug development followed that logic. That story isn’t exactly wrong. But it is increasingly incomplete. What if depression isn’t primarily a brain disorder - but a network disorder?

Five controllable factors that determine whether your next executive hire accelerates progress or derails your search.